Comparison of Paravertebral Block and Subcostal Transversus Abdominis Plane Block in Laparoscopic Nephrectomy
Comparison of Postoperative Analgesic Effects of Ultrasonography-Guided Paravertebral Block and Subcostal Transversus Abdominis Plane Block in Patients Undergoing Laparoscopic Nephrectomy
1 other identifier
interventional
91
1 country
1
Brief Summary
Most of the patients undergoing laparoscopic partial/radical nephrectomy can experience moderate or severe postoperative pain, and inadequate control of this pain can cause negative consequences such as development of chronic pain, pulmonary and cardiac events, and side effects of long term opioid usage. Due to these adverse outcomes, ultrasonography-guided plane blocks can be beneficial for these patients to decrease opioid consumption. In this study, the investigators aim to compare ultrasonography-guided plane blocks: Paravertebral block and subcostal transversus abdominis plane block and traditional method: patient controlled analgesia with opioids. The investigators hypothesized that analgesic efficacy in both paravertebral and subcostal TAP blocks will have similar outcomes but better than traditional method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2023
CompletedFirst Posted
Study publicly available on registry
February 10, 2023
CompletedStudy Start
First participant enrolled
February 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedMarch 12, 2024
March 1, 2024
8 months
February 3, 2023
March 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Intravenous Total Morphine Consumption
The total dosage of intravenous morphine consumption in 24 hours.
Up to 24 hours
Secondary Outcomes (5)
Postoperative Visual Analog Score (VAS)
Up to 24 hours
Rescue analgesia administration amounts
Up to 24 hours
Incidence of complications due to the regional blocks
Up to first week
Chronic postoperative pain
Up to 90th day
Lenght of Hospital Stay
Up to first week
Other Outcomes (6)
Indidence of PONV (postoperative nausea and vomiting)
Up to 24 hours
Respiratuar Depression
Up to 24 hours
Postoperative Ramsay Sedation Scale (RSS)
Up to 24 hours
- +3 more other outcomes
Study Arms (3)
Paravertebral Block Group
ACTIVE COMPARATORIn this group, preoperative ultrasound-guided paravertebral block will be performed ipsilateraly via peripheral block needle with 20 ml bupivacaine %0,25 in the paravertebral space.
Subcostal Transversus Abdominis Plane Block Group
ACTIVE COMPARATORIn this group, preoperative ultrasound-guided subcostal transversus abdominis plane block will be performed ipsilateraly via peripheral block needle with 20 ml bupivacaine %0,25 into the fascial plane between erector spine muscle and transverse process
Intravenous Patient Controlled Analgesia
ACTIVE COMPARATORIn this group, postoperative patient controlled analgesia with morphine will be preferred for postoperative analgesia method.
Interventions
%0,25
In this group, patients will be postoperatively administered patient-controlled analgesia with morphine only.
Eligibility Criteria
You may qualify if:
- Age of 18-75
- Patients who are ASA (American Society of Anesthesiology): I-II
- Patients who will have laparoscopic partial/radical nephrectomy
- Patients who volunteer to participate in the study
You may not qualify if:
- Patients with any kind of coagulopathy
- Patients with severe cardiac, pulmonary, renal or liver disease
- Patients who have difficulty comprehending the IV PCA device
- Patients with local anesthetic allergy
- Patients with chronic opioid use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University
Istanbul, Turkey (Türkiye)
Related Publications (4)
Qu G, Cui XL, Liu HJ, Ji ZG, Huang YG. Ultrasound-guided Transversus Abdominis Plane Block Improves Postoperative Analgesia and Early Recovery in Patients Undergoing Retroperitoneoscopic Urologic Surgeries: A Randomized Controlled Double-blinded Trial. Chin Med Sci J. 2016 Sep 20;31(3):137-141. doi: 10.1016/s1001-9294(16)30041-4.
PMID: 27733219BACKGROUNDSchwarz F, Preusler W, Reifart N, Storger H, Hofmann M, Holscher I. [The long-term success after coronary angioplasty in old age]. Dtsch Med Wochenschr. 1993 Apr 30;118(17):609-14. doi: 10.1055/s-2008-1059369. German.
PMID: 8482238BACKGROUNDCopik M, Bialka S, Daszkiewicz A, Misiolek H. Thoracic paravertebral block for postoperative pain management after renal surgery: A randomised controlled trial. Eur J Anaesthesiol. 2017 Sep;34(9):596-601. doi: 10.1097/EJA.0000000000000673.
PMID: 28731925BACKGROUNDParikh BK, Waghmare VT, Shah VR, Mehta T, Butala BP, Parikh GP, Vora KS. The analgesic efficacy of ultrasound-guided transversus abdominis plane block for retroperitoneoscopic donor nephrectomy: A randomized controlled study. Saudi J Anaesth. 2013 Jan;7(1):43-7. doi: 10.4103/1658-354X.109808.
PMID: 23717232BACKGROUND
Related Links
- Ultrasound-guided Transversus Abdominis Plane Block Improves Postoperative Analgesia and Early Recovery in Patients Undergoing Retroperitoneoscopic Urologic Surgeries: A Randomized Controlled Double-blinded Trial
- Single injection paravertebral block for renal surgery in children
- Thoracic paravertebral block for postoperative pain management after renal surgery A randomised controlled trial
- The analgesic efficacy of ultrasound-guided transversus abdominis plane block for retroperitoneoscopic donor nephrectomy: A randomized controlled study
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Meltem Savran Karadeniz, MD
Istanbul Faculty of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
February 3, 2023
First Posted
February 10, 2023
Study Start
February 15, 2023
Primary Completion
October 1, 2023
Study Completion
February 1, 2024
Last Updated
March 12, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share